Keyphrases
Congestive Heart Failure
100%
Epoprostenol
100%
Acute Decompensated Heart Failure
20%
6-minute Walk Test (6MWT)
20%
Dose Titration
20%
Severe Heart Failure
20%
First Week
20%
Conventional Therapy
20%
Vasodilator
10%
Dose-ranging Study
10%
Intravenous Infusion
10%
Cardiac Index
10%
Prior Treatment
10%
Functional Outcome
10%
Adverse Effects
10%
Drug Delivery System
10%
Vasodilation
10%
Clinical Benefit
10%
Left Ventricular Ejection Fraction
10%
New York Heart Association Class
10%
Pulmonary Capillary Wedge Pressure
10%
Prostacyclin
10%
Systemic Vascular Resistance
10%
Diuretics
10%
Initial Dose
10%
Pulmonary Vascular Resistance
10%
Dobutamine
10%
Digitalis
10%
Dose Adjustment
10%
Intravenous Treatment
10%
High Mortality Rate
10%
Distance Walked
10%
Ventricular Dysfunction
10%
Refractory Heart Failure
10%
Invasive Hemodynamics
10%
Concomitant Medications
10%
Indwelling Central Venous Catheter
10%
Portable Infusion Pump
10%
Angiotensin-converting Enzyme Inhibitor (ACEi)
10%
Medicine and Dentistry
Congestive Heart Failure
100%
Prostacyclin
100%
Heart Failure
45%
Infusion
36%
Drug Dose Titration
18%
Six Minute Walk Test
18%
Scanning Electron Microscopy
9%
Vasodilatation
9%
Symptom
9%
Hemodynamic
9%
Intravenous Drug Administration
9%
Drug Therapy
9%
Dose-Ranging Study
9%
Adverse Event
9%
New York Heart Association Class
9%
Diuretic Agent
9%
Mortality Rate
9%
Drug Delivery System
9%
Heart Left Ventricle Ejection Fraction
9%
ACE Inhibitor
9%
Pulmonary Artery Occlusion Pressure
9%
Systemic Vascular Resistance
9%
Vasodilator Agent
9%
Heart Ventricle Function
9%
Hemodynamic Monitoring
9%
Lung Vascular Resistance
9%
Central Venous Catheter
9%
Dobutamine
9%
Pharmacology, Toxicology and Pharmaceutical Science
Congestive Heart Failure
100%
Prostacyclin
100%
Heart Failure
45%
Drug Delivery System
9%
Scanning Electron Microscopy
9%
Vasodilator Agent
9%
Symptom
9%
Adverse Event
9%
Dipeptidyl Carboxypeptidase Inhibitor
9%
Diuretic Agent
9%
Mortality Rate
9%
Dobutamine
9%
Infusion Pump
9%